[1]
Venanti, B.S., Rizky Danang Susetyo, Hilmy Irsyadi Hanif, Tri Murti Andayani and Zullies Ikawati 2025. Cost-effectiveness of immune checkpoint inhibitors and chemotherapy in triple-negative breast cancer: a scoping review. Indonesian Journal of Pharmacology and Therapy. 6, 3 (Oct. 2025), 166-179. DOI:https://doi.org/10.22146/ijpther.21778.